Market Cap 363.15B
Revenue (ttm) 56.33B
Net Income (ttm) 4.28B
EPS (ttm) N/A
PE Ratio 20.03
Forward PE 16.48
Profit Margin 7.59%
Debt to Equity Ratio 19.96
Volume 11,093,831
Avg Vol 6,507,388
Day's Range N/A - N/A
Shares Out 1.77B
Stochastic %K 47%
Beta 0.61
Analysts Strong Sell
Price Target $211.29

Latest News on ABBV

Best Dividend Aristocrats For April 2025

Mar 31, 2025, 4:07 PM EDT - 4 hours ago

Best Dividend Aristocrats For April 2025

ABT ADM BDX BEN BRO CAH CL


AbbVie: Margin Expansion Potential Can Support Elevated P/E

Mar 31, 2025, 10:20 AM EDT - 9 hours ago

AbbVie: Margin Expansion Potential Can Support Elevated P/E


AbbVie to Host First-Quarter 2025 Earnings Conference Call

Mar 31, 2025, 8:00 AM EDT - 12 hours ago

AbbVie to Host First-Quarter 2025 Earnings Conference Call


Final Trades: PayPal, Meta, Abbvie and Snowflake

Mar 28, 2025, 1:18 PM EDT - 3 days ago

Final Trades: PayPal, Meta, Abbvie and Snowflake

META PYPL SNOW


AbbVie Vs. Sanofi: Which Is The Better Investment Right Now

Mar 28, 2025, 9:44 AM EDT - 3 days ago

AbbVie Vs. Sanofi: Which Is The Better Investment Right Now

SNY


2025 Dividend Kings: Strong Run Continues

Mar 21, 2025, 12:59 PM EDT - 10 days ago

2025 Dividend Kings: Strong Run Continues

ABM ABT ADM AWR BDX BKH CWT


Widely used drugs on US imports list from Europe

Mar 18, 2025, 1:03 PM EDT - 13 days ago

Widely used drugs on US imports list from Europe

AMGN


AbbVie Is Preparing To Challenge Eli Lilly And Novo Nordisk

Mar 13, 2025, 3:55 PM EDT - 18 days ago

AbbVie Is Preparing To Challenge Eli Lilly And Novo Nordisk


Darst's Stock Picks: GOLD, EL, ABBV

Mar 8, 2025, 4:00 PM EST - 23 days ago

Darst's Stock Picks: GOLD, EL, ABBV

EL GOLD


5 Big Biopharmaceutical Stocks That Are Finding Favor

Mar 5, 2025, 1:31 PM EST - 26 days ago

5 Big Biopharmaceutical Stocks That Are Finding Favor

AMGN GILD JNJ LLY


Why AbbVie Remains A Strong Buy For Long-Term Investors

Feb 23, 2025, 11:52 AM EST - 5 weeks ago

Why AbbVie Remains A Strong Buy For Long-Term Investors


AbbVie Appears Ready To Move Higher

Feb 18, 2025, 10:55 PM EST - 5 weeks ago

AbbVie Appears Ready To Move Higher


The Big 3: ABBV, EA, CEG

Feb 14, 2025, 11:58 AM EST - 6 weeks ago

The Big 3: ABBV, EA, CEG

EA CEG


AbbVie: An Undervalued Dividend Aristocrat

Feb 14, 2025, 11:00 AM EST - 6 weeks ago

AbbVie: An Undervalued Dividend Aristocrat


AbbVie Declares Quarterly Dividend

Feb 13, 2025, 11:57 AM EST - 6 weeks ago

AbbVie Declares Quarterly Dividend